Leela Barham highlights data that shows that indication-specific pricing has been used in England for at least four years and over 60 times. Lessons from that experience should be used to provide ...

The Cochrane Oral Health Group's Trials Register, Cochrane CENTRAL (Cochrane Library), Medline and Embase were used to identify likely studies. OpenSIGLE, * CBMdisc (the Chinese Biomedical Literature ...

As Amgen waits for an FDA decision on a second indication for its B cell-depleting therapy Uplizna, it has new data suggesting a third may be coming down the pipe. New data from the phase 3 MINT trial ...

Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group Authors retain all rights in ...

This review covers the most recent articles on temporomandibular joint arthrocentesis, focusing on its mechanism of action, indications, clinical outcomes and efficacy, complications, comparison with ...

Kayshild, a semaglutide formulation, is the first GLP-1 receptor agonist approved for non-cirrhotic MASH with liver fibrosis, expanding metabolic therapy markets. Ilumira, a radiopharmaceutical ...

Siliguri: Mandarin orange, grown in the hills of Darjeeling in West Bengal and known for its quality and sweetness, has been granted Geographical Indication (GI) status, people aware of the ...

Sotatercept-csrk is approved for improving exercise capacity and reducing clinical worsening in PAH patients, following FDA label expansion. The ZENITH trial showed a 76% reduction in major morbidity ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a supplemental new drug application that updates the indication statement for upadacitinib ...

The FDA has approved an expanded indication for risperidone (Uzedy, Teva) extended-release injectable suspension, allowing it to be used for the maintenance treatment of bipolar I disorder in adults, ...

The US Food and Drug Administration has expanded the indication for evolocumab (Repatha) to include a wider swath of patients at high risk for cardiovascular disease due to elevated LDL cholesterol ...

The FDA expanded Repatha's label to include adults at increased risk for MACE due to uncontrolled LDL-C, broadening access beyond those with diagnosed CVD. Repatha is now approved as a standalone ...